Patricia E. Miller Inc. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 20 Ridge St, Middletown, NY 10940 Phone: 845-343-2500 Fax: 845-343-1077 |
Galleria Mall Dental Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1 N Galleria Dr Ste 141, Middletown, NY 10941 Phone: 845-692-9212 Fax: 845-692-9215 |
Orange County Dental Services Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 453 Route 211 E, Suite 103, Middletown, NY 10940 Phone: 845-344-1003 |
Dba Bracesetters Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 180 Wisner Ave, Middletown, NY 10940 Phone: 845-342-1300 Fax: 845-344-0013 |
Jeffrey Kim Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 400 Midway Park Dr, Middletown, NY 10940 Phone: 845-344-4336 |
News Archive
Supelco, a division of Sigma-Aldrich®, announced today the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design. This column design exhibits very high column efficiency, providing a stable, reversed phase packing with a pore structure and pore size that is optimized for reversed-phase HPLC separations of peptides and polypeptides.
A University of Oklahoma researcher is developing a novel therapy for Alzheimer's disease using "biopharmaceutical proteases" to attack the toxic plaque that builds up in the brain of an Alzheimer's patient-an approach that he predicts will be lower in cost and higher in effectiveness than current therapies.
The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.
Cocaine-addicted individuals say they find the drug much less enjoyable after years of use, but they have great difficulty quitting.
The European Commission is funding a two year, -500,000 project to co-ordinate European and international research into the development of new drugs to treat malaria.
› Verified 1 days ago